OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Resistance to anti-PD1 therapies in patients with advanced melanoma: systematic literature review and application of the Society for Immunotherapy of Cancer Immunotherapy Resistance Taskforce anti-PD1 resistance definitions
Irene M. Shui, Emilie Scherrer, Andrew M. Frederickson, et al.
Melanoma Research (2022) Vol. 32, Iss. 6, pp. 393-404
Closed Access | Times Cited: 8
Irene M. Shui, Emilie Scherrer, Andrew M. Frederickson, et al.
Melanoma Research (2022) Vol. 32, Iss. 6, pp. 393-404
Closed Access | Times Cited: 8
Showing 8 citing articles:
Immune Checkpoint Inhibitors: A Narrative Review on PD-1/PD-L1 Blockade Mechanism, Efficacy, and Safety Profile in Treating Malignancy
Nicolas D Benelli, Ian Brandon, Karina E. Hew
Cureus (2024)
Open Access | Times Cited: 4
Nicolas D Benelli, Ian Brandon, Karina E. Hew
Cureus (2024)
Open Access | Times Cited: 4
Evolving cancer resistance to anti-PD-1/PD-L1 antibodies in melanoma: Comprehensive insights with future prospects
W. Li, Junjie Gu, Hongwei Fan, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104426-104426
Open Access | Times Cited: 3
W. Li, Junjie Gu, Hongwei Fan, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104426-104426
Open Access | Times Cited: 3
Extracellular Vesicles in Cancer Drug Resistance: Implications on Melanoma Therapy
Alice Musi, Laura Bongiovanni
Cancers (2023) Vol. 15, Iss. 4, pp. 1074-1074
Open Access | Times Cited: 7
Alice Musi, Laura Bongiovanni
Cancers (2023) Vol. 15, Iss. 4, pp. 1074-1074
Open Access | Times Cited: 7
Melanom
Selma Ugurel, Ralf Gutzmer
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 4, pp. 343-348
Closed Access | Times Cited: 7
Selma Ugurel, Ralf Gutzmer
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 4, pp. 343-348
Closed Access | Times Cited: 7
Genomic and molecular alterations associated with primary resistance to immune checkpoint inhibitors
Jyoti Malhotra, Subhajyoti De, Kim B. Nguyen, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 1
Jyoti Malhotra, Subhajyoti De, Kim B. Nguyen, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 1
Higher Nodal expression is often associated with poorer survival in patients diagnosed with melanoma and treated with anti-PD1 therapy
Philippe D. Gascard, Xianhong Wang, Mehdi Nosrati, et al.
Pathology & Oncology Research (2024) Vol. 30
Open Access
Philippe D. Gascard, Xianhong Wang, Mehdi Nosrati, et al.
Pathology & Oncology Research (2024) Vol. 30
Open Access
Knowledge graph and frontier trends in melanoma-associated ncRNAs: a bibliometric analysis from 2006 to 2023
Ru Wang, Xiaoyan Zhu, Yi Wang
Frontiers in Oncology (2024) Vol. 14
Open Access
Ru Wang, Xiaoyan Zhu, Yi Wang
Frontiers in Oncology (2024) Vol. 14
Open Access
